-On Friday 19 June- over 260 people joined our webinar, in partnership with Lymphoma Action, to hear our panel of UK experts answer some of the most commonly asked questions around COVID-19 and Waldenstrom’s macroglobulinaemia (WM).
A recording of the webinar is now available here for those who were not able to join us on the day, or who wish to watch it again, along with answers to some of the questions not covered during the actual session.
WMUK Chief Executive, Lindsey Bennister said “We hope that the webinar was useful for people affected by WM. Following the success of this first session, we are now looking to host further webinars around this and other topics relevant for people affected by WM.
We would like to offer our sincere thanks to our panel of UK experts; Dr Shirley D’Sa and Helen DeMarco, our co-host Stephen Scowcroft and the team at Lymphoma Action, as well as everyone who participated in the webinar and submitted their questions to the panel in advance.
This is an opportunity to ask questions about COVID-19 and WM to our panel of UK experts – Dr Shirley D’Sa, WM lead clinician at University College London Hospitals (UCLH) and WMUK trustee; and Helen DeMarco, Consultant Clinical & Health Psychologist in the Haematology Psychology and Counselling Services at University College London Hospitals (UCLH).
Coronavirus (COVID-19) has had a huge impact on our lives in the last few months and could well continue to do so into the future. At WMUK, people with WM have been in touch with a wide range of questions about COVID-19 and WM as well as seeking support for how to cope physically, mentally, and emotionally with lockdown and shielding. We hope this webinar will give you facts, information, and tools for living well with WM during COVID-19.
To register for this event, simply click on the link below. Full joining instructions will be sent once your registration is confirmed.
Note: Some of the content will be specific to the medical system in the UK but much of it will be suitable to an international audience.